Amplitude Surgical - 9-Months Consolidated Sales for FY 2024-25 of €83.8m, up +6.4% at Constant Exchange Rates

• Sales up +6.6% at constant exchange rates in Q3 FY 2024-25
• Consolidated sales for 9 months up+ 6.4% at constant exchange rates to €83.8m
• Good momentum in France: sales up +4.7% over 9 months
• Strong international business: sales up +11.1% at constant exchange rates over 9 months

VALENCE, France--(BUSINESS WIRE)--Regulatory News:

Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its consolidated sales for the third quarter of the 2024-25 financial year.

Olivier Jallabert, Chief Executive Officer of Amplitude Surgical, comments: "In the first 9 months of the 2024-25 financial year, Amplitude Surgical continued its growth trajectory, posting sales growth of +6.4% at constant exchange rates compared with the same period last year. Business grew both in France, with an increase of +4.7%, and internationally, with growth of +11.1% at constant exchange rates."

Consolidated sales 9 months of FY 2024-25

Sales 9M 2024-25	31/03/2025	31/03/2024	Change at current exchange rates	Change at constant exchange rates
In K€ - IFRS
Knee and hip activities	83 813	79 614	5,3%	6,4%
Total	83 813	79 614	5,3%	6,4%

Sales Q3 2024-25	31/03/2025	31/03/2024	Change at current exchange rates	Change at constant exchange rates
In K€ - IFRS
Knee and hip activities	32 310	30 557	5,7%	6,6%
Total	32 310	30 557	5,7%	6,6%

For the first 9 months (July 2004 - March 2025) of the 2024-25 financial year, Amplitude Surgical sales came to €83.8 million, up +5.3% and +6.4% at constant exchange rates.

Over the 9 months, sales of knees and hips rose by +4.7% in France and by +11.1% at constant exchange rates outside France. Within the international perimeter, international distributors were up +6.6%, and the Group's international subsidiaries recorded a +7.1% increase at current exchange rates, and a +12.6% increase at constant exchange rates.

For the third quarter 2024-25, growth was 6.6% at constant exchange rates, in line with the Group's 9-month performance, with a 4.8% increase in France, a 12.4% increase at constant exchange rates for the Group's international subsidiaries, and a 12.3% increase for international distributors.

Amplitude Surgical's direct sales (French market and international subsidiaries), which account for almost 93% of total Group sales, rose by +6.4% at constant exchange rates.

France accounted for around 72% of Group sales in the first 9 months of the 2024-25 financial year.

International subsidiaries reported growth at constant exchange rates in Belgium, Australia, Brazil and South Africa, while sales in Germany and Switzerland were down.

Next press release:

Annual sales 2024-25: Thursday, July 24, 2025, after market close.

About Amplitude Surgical

Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery, covering the main pathologies affecting the hip and knee. Working in close collaboration with surgeons, Amplitude Surgical develops numerous high value-added innovations to best meet the needs of patients, surgeons and care facilities. A leading player in France, Amplitude Surgical is expanding internationally through its subsidiaries and a network of agents and exclusive distributors in over 30 countries. At June 30, 2024, Amplitude Surgical had 428 employees and sales of nearly 106.0 million euros.